Epidemiology Faces Its Limits: The search for subtle links between diet, lifestyle, or environmental factors and disease is an unending source of fear—but often yields little certainty

Taubes, Gary·1995·Science
DOI 10.1126/science.7618077

Cited by (835)

Items 301–400 of 835

  1. “Impact? What impact?” Epidemiological research findings in the public domain: a case study from north-east England
    Suzanne M Moffatt, Peter Phillimore, E Hudson, D Downey · 2000 · Social Science & Medicine
  2. Challenging the epidemiologic evidence on passive smoking: tactics of tobacco industry expert witnesses
    John A Francis, Amy K Shea, Jonathan M. Samet · 2006 · Tobacco Control
  3. Calcium Channel Blockers for Hypertension Dissecting the Evidence for Adverse Effects
    Lionel Henry Opie · 1997 · American Journal of Hypertension
  4. Lignan Precursors From Flaxseed or Rye Bran Do Not Protect Against the Development of Intestinal Neoplasia in ApcMin Mice
    Henk J. van Kranen, Alicja Mortensen, Ilona Kryspin Sørensen, Jolanda van den Berg-Wijnands, Rudolf B. Beems, Tarja Nurmi, Herman Adlercreutz, Coen F. van Kreijl · 2003 · Nutrition and Cancer
  5. Tyranny of the p-Value: The Conflict between Statistical Significance and Common Sense
    Michael L. Barnett, Annette L Mathisen · 1997 · Journal of Dental Research
  6. The development of scientific evidence for health policies for obesity: why and how?
    Molly Richardson, Michelle S. Williams, Kevin R. Fontaine, David B. Allison · 2017 · International Journal of Obesity
  7. Examining the robustness of observational associations to model, measurement and sampling uncertainty with the vibration of effects framework
    Simon Klau, Sabine Hoffmann, Chirag J. Patel, John P. A. Ioannidis, Anne‐Laure Boulesteix · 2020 · International Journal of Epidemiology
  8. The history, genotoxicity, and carcinogenicity of carbon-based fuels and their emissions: Part 5. Summary, comparisons, and conclusions
    Larry D. Claxton · 2014 · Mutation Research/Reviews in Mutation Research
  9. Preregistration of Epidemiology Protocols
    Michael B. Bracken · 2011 · Epidemiology
  10. From Miasma to Fractals: The Epidemiology Revolution and Public Health Nursing
    Marjorie MacDonald · 2004 · Public Health Nursing
  11. Cancer risk assessment: Optimizing human health through linear dose–response models
    Edward J. Calabrese, Dima Yazji Shamoun, Jaap C. Hanekamp · 2015 · Food and Chemical Toxicology
  12. Weight-of-evidence evaluation of long-term ozone exposure and cardiovascular effects
    Robyn L. Prueitt, Heather N. Lynch, Ke Zu, Sonja N. Sax, Ferdinand J. Venditti, Julie E. Goodman · 2014 · Critical Reviews in Toxicology
  13. Causal inference challenges in social epidemiology: Bias, specificity, and imagination
    M. Maria Glymour, Kara E. Rudolph · 2016 · Social Science & Medicine
  14. Long-term exposure to ambient air pollution, genetic susceptibility, and the incidence of bipolar disorder: A prospective cohort study
    Dankang Li, Yudiyang Ma, Feipeng Cui, Yingping Yang, Run Liu, Linxi Tang, Jianing Wang, Yaohua Tian · 2023 · Psychiatry Research
  15. An Introduction to Epidemiology
    Wolfgang Ahrens, Klaus Krickeberg, Iris Pigeot · 2013 · Springer eBooks
  16. Gene-environment interaction and male reproductive function
    Jonatan Axelsson, Jens Peter Bonde, Yvonne Lundberg Giwercman, Lars Rylander, Aleksander Giwercman · 2010 · Asian Journal of Andrology
  17. Response Bias in Self-Reported History of Plaintiffs Compared with Nonlitigating Patients
    Paul R. Lees‐Haley, Christopher W. Williams, Lue T. English · 1996 · Psychological Reports
  18. Holism and the idea of general susceptibility to disease
    Stephen J. Kunitz · 2002 · International Journal of Epidemiology
  19. Weak electromagnetic fields and cancer in the context of risk assessment
    Kenneth R. Foster, L.S. Erdreich, John E. Moulder · 1997 · Proceedings of the IEEE
  20. HRT and breast cancer: a million women ride again
    John C. Stevenson, Richard D T Farmer · 2020 · Climacteric
  21. Evidence that Human Prostate Cancer is a ZIP1-Deficient Malignancy that could be Effectively Treated with a Zinc Ionophore (Clioquinol) Approach
    Leslie C. Costello · 2014 · Chemotherapy Open access
  22. Association between gastric acid suppressants and Clostridium difficile colitis and community-acquired pneumonia: analysis using pharmacovigilance tools
    Manfred Hauben, Sebastian Horn, Lester Reich, Muhammad Younus · 2007 · International Journal of Infectious Diseases
  23. Evidence-Based Toxicology: “Sound Science” in New Disguise
    Christina Rudén, Sven Ove Hansson · 2008 · International Journal of Occupational and Environmental Health
  24. Cardiovascular Effects after Inhalation of Large Doses of Albuterol Dry Powder in Rats, Monkeys, and Dogs: A Species Comparison
    Janet M. Petruska · 1997 · Fundamental and Applied Toxicology
  25. The withdrawal of rofecoxib
    Felix M Arellano · 2005 · Pharmacoepidemiology and Drug Safety
  26. Vivendo entre exposições e agravos: a teoria da relatividade do risco
    Luís David Castiel · 1996 · História Ciências Saúde-Manguinhos
  27. The Calcium Antagonist Controversy: The Emerging Importance of Drug Formulation as a Determinant of Risk
    Murray Epstein · 1997 · The American Journal of Cardiology
  28. Registration of protocols for observational research is unnecessary and would do more harm than good
    Neil E. Pearce · 2010 · Occupational and Environmental Medicine
  29. The triumph of the null hypothesis: epidemiology in an age of change
    Wasim Maziak · 2008 · International Journal of Epidemiology
  30. Acquisition and baseline performance of working memory tasks by adolescent rhesus monkeys
    Christopher D. Verrico, S. Liu, Josephine K Asafu-Adjei, Allan R. Sampson, Charles W. Bradberry, David A. Lewis · 2011 · Brain Research
  31. Some implications of genetic biomarkers in occupational epidemiology and practice
    Paul A. Schulte · 2004 · Scandinavian Journal of Work Environment & Health
  32. Uncertainties relating to the health effects of particulate air pollution: The US EPA's particle standard
    RF Phalen · 1998 · Toxicology Letters
  33. Strength of Association. Report 1. Graduations of Relative Risk
    Aleksey N. Koterov, Liliya N. Ushenkova, Э. Зубенкова, A.A. Vainson, A. Vaynson, M.V. Kalinina, А. П. Бирюков, Aleksandr P. Biryukov · 2019 · Medical Radiology and radiation safety
  34. Elevated hippocampal copper in cases of type 2 diabetes
    Sasha A. Philbert, Sarah J. Schönberger, Jingshu Xu, Stephanie J. Church, Richard D. Unwin, Garth J. S. Cooper · 2022 · EBioMedicine
  35. Levels of Clinical Significance
    Philippe Pierre Hujoel · 2004 · Journal of Evidence Based Dental Practice
  36. An epidemiological perspective on one tale of a two-tailed hypothesis
    Daniel J. Foley · 2004 · Sleep Medicine Reviews
  37. Stochastic Modelling of Drinking Water Treatment in Quantitative Microbial Risk Assessment
    Patrick Smeets · 2010 · Water Intelligence Online
  38. Registration of Observational Studies: perspectives from an industry‐based epidemiology group
    Scott Chavers, Daniel Fife, Mary C. Wacholtz, Paul Stang, Jesse A. Berlin · 2011 · Pharmacoepidemiology and Drug Safety
  39. Epidemiology, medicine and public health
    Hans‐Olov Adami, Dimitrios Trichopoulos · 1999 · International Journal of Epidemiology
  40. Vaccines: predicting the risk of allergy and autoimmunity
    Jacques Descotes, Guillaume Ravel, C. Ruat · 2002 · Toxicology
  41. Infant Diets and Type 1 Diabetes
    Mark A. Atkinson, Edwin AM Gale · 2003 · JAMA
  42. Fulfilling the promise of Mendelian randomization
    Joseph K. Pickrell · 2015 · bioRxiv (Cold Spring Harbor Laboratory)
  43. The Discipline of Epidemiology
    Dimitrios Trichopoulos · 1995 · Science
  44. Diet and health risk: risk patterns and disease-specific associations
    Marshall, James R, Chen, Zhao · 1999 · The American Journal of Clinical Nutrition
  45. Applicability of extracellular vesicles in clinical studies
    Domen Vozel, Bojana Uršič, Judita Lea Krek, Roman Štukelj, Veronika Kralj‐Iglič · 2017 · European Journal of Clinical Investigation
  46. The history of confounding
    Jan Paul Vandenbroucke · 2002 · Sozial- und Präventivmedizin
  47. Cosmetic Talc Should Not Be Listed as a Carcinogen: Comments on NTP's Deliberations to List Talc as a Carcinogen
    Alfred P. Wehner · 2002 · Regulatory Toxicology and Pharmacology
  48. Sleep duration and cancer risk: time to use a “sleep-years” index?
    Thomas C. Erren · 2012 · Cancer Causes & Control
  49. Popper y el problema de la inducción en epidemiología
    José R. Banegas, Fernando Rodríguez‐Artalejo, Juan del Rey Calero · 2000 · Revista Española de Salud Pública
  50. Controversy and Debate: Memory Based Methods Paper 3: Nutrition's ‘Black Swans’: Our reply
    Edward Archer, Michael L. Marlow, Carl J. Lavie · 2018 · Journal of Clinical Epidemiology
  51. Critical appraisal of recent studies on nifedipine and other calcium channel blockers in coronary artery disease and hypertension
    Jan G.P. Tijssen, P. G. HUGENHOLTZ · 1996 · European Heart Journal
  52. Induced Abortion, Bias, and Breast Cancer: Why Epidemiology Hasn't Reached Its Limit
    Douglas L. Weed, Barnett S. Kramer · 1996 · JNCI Journal of the National Cancer Institute
  53. Projection of future numbers of mesothelioma cases in the US and the increasing prevalence of background cases: an update based on SEER data for 1975 through 2018
    Bertram P. Price · 2022 · Critical Reviews in Toxicology
  54. Vaccination and Risk of Childhood IgA Vasculitis
    Maryam Piram, Solange Gonzalez Chiappe, Fouad Madhi, Tim Ulinski, Alfred Mahr · 2018 · PEDIATRICS
  55. What an anticardiovascular diet should be in 2015
    David R. Jacobs, Linda C Tapsell · 2015 · Current Opinion in Lipidology
  56. The Costly Illusion of Regulating Unknowable Risks
    Gio Batta Gori · 2001 · Regulatory Toxicology and Pharmacology
  57. Beyond the year 2000: How may epidemiology influence future clinical practice in dermatology?
    Hywel C Williams · 2001 · Clinics in Dermatology
  58. “True Believers” or Numerical Terrorism at the Nuclear Power Plant
    Walter Krämer, Gerhard Arminger · 2011 · De Gruyter eBooks
  59. Evolution of Cancer Epidemiology
    Martha S. Linet · 2000 · Epidemiologic Reviews
  60. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration
    Jan Paul Vandenbroucke, Erik B von Elm, Douglas G. Altman, Peter Christian Gøtzsche, Cynthia D. Mulrow, Stuart Pocock, Charles Poole, James J. Schlesselman, Matthias Egger · 2022 · Вопросы современной педиатрии
  61. The Mutographs biorepository: A unique genomic resource to study cancer around the world
    Sandra P. Perdomo, Behnoush Abedi‐Ardekani, Ana Carolina de Carvalho, Aida Ferreiro-Iglesias, Valérie Gaborieau, Thomas Cattiaux, Hélène Renard, Priscilia Chopard, Christine Carreira, Andreea Spanu et al. · 2024 · Cell Genomics
  62. The Epidemiologic Toolbox: Identifying, Honing, and Using the Right Tools for the Job
    Catherine R. Lesko, Alexander P. Keil, Jessie K. Edwards · 2020 · American Journal of Epidemiology
  63. Navigating the perfect [data] storm
    Madeleine J. Murtagh, Guðmundur Á. Þórisson, S.E. Wallace, Jane S. Kaye, İpek Demir, Isabel Fortier, Jennifer Ruth Harris, David Cox, M. Deschênes, Philippe Laflamme et al. · 2012 · Norsk Epidemiologi
  64. Community-Based Epidemiology
    Mark Haskell Smith · 1998 · Journal of Health & Social Policy
  65. Epidemiology: second-rate science?
    Mark J. Parascandola · 1998 · PubMed Central
  66. Detecting measurement confounding in epidemiological research: construct validity in scaling risk behaviours: based on a population sample in Minnesota, USA
    Kimberlie Dean, N. Salem · 1998 · Journal of Epidemiology & Community Health
  67. Methods for meta-analysis of individual participant data from Mendelian randomisation studies with binary outcomes
    Stephen Burgess, Simon G. Thompson · 2012 · Statistical Methods in Medical Research
  68. Petitions in scientific argumentation: Dissecting the request to retire statistical significance
    Tom Elis Hardwicke, John P. A. Ioannidis · 2019 · European Journal of Clinical Investigation
  69. Weight-of-evidence evaluation of short-term ozone exposure and cardiovascular effects
    Julie E. Goodman, Robyn L. Prueitt, Sonja N. Sax, Heather N. Lynch, Ke Zu, Julie C. Lemay, Joseph M. King, Ferdinand J. Venditti · 2014 · Critical Reviews in Toxicology
  70. Linking causal concepts, study design, analysis and inference in support of one epidemiology for population health
    Wayne Martin · 2008 · Preventive Veterinary Medicine
  71. Accelerating Protein Biomarker Discovery and Translation From Proteomics Research for Clinical Utility
    Jiwen Chen, Naiyu Zheng · 2020 · Bioanalysis
  72. An Introduction to Epidemiology
    Wolfgang Ahrens, Klaus Krickeberg, Iris Pigeot · 2005 · Springer eBooks
  73. Neurologic Evaluation of Workers Previously Diagnosed With Solvent-Induced Toxic Encephalopathy
    James W. Albers, John J. Wald, David H. Garabrant, Christine L. Trask, Stanley Berent · 2000 · Journal of Occupational and Environmental Medicine
  74. Legal Questions and Scientific Answers : Ontological Differences and Epistemic Gaps in the Assessment of Causal Relations
    Lena Wahlberg · 2010 · Lund University Publications (Lund University)
  75. Commentary: Fat and breast cancer: time to re-evaluate both methods and results?
    Sheila Anne Bingham, Nicholas E. Day · 2006 · International Journal of Epidemiology
  76. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration. Translation to Russian
    Jan Paul Vandenbroucke, Erik B von Elm, Douglas G. Altman, Peter Christian Gøtzsche, Cynthia D. Mulrow, Stuart Pocock, Charles Poole, James J. Schlesselman, Matthias Egger · 2021 · Digital Diagnostics
  77. Evaluating the relation between changeability decay and the characteristics of clones and methods
    Angela Lozano, Michel Wermelinger B, Bashar Nuseibeh · 2008 · IEEE/ACM International Conference on Automated Software Engineering Workshops (ASEW)
  78. Algumas Questões sobre o Desenvolvimento da Epidemiologia na América Latina
    Rita Barradas Barata, Maurício L. Barreto · 1996 · Ciência & Saúde Coletiva
  79. Risks, risk assessment and risk competence in toxicology
    Ralf Stahlmann, Horvath, Aniko · 2015 · PubMed Central
  80. Causalidade e epidemiologia
    Rita Barradas Barata · 1997 · História Ciências Saúde-Manguinhos
  81. Epidemiology and Culture
    James Trostle · 2005 · Cambridge University Press eBooks
  82. Air pollution and daily admissions for chronic obstructive pulmonary disease in six European cities: results from the APHEA project. Air Pollution and Health, a European Approach
    B Hasford, Günter Fruhmann · 1998 · European Respiratory Journal
  83. Assessing and evaluating the health impact of environmental exposures
    A.E.M. de Hollander · 2004 · Utrecht University Repository (Utrecht University)
  84. How Public Health Policy Is Created: Scientific Process and Political Reality
    Alfred H. Sommer · 2001 · American Journal of Epidemiology
  85. The Discipline of Epidemiology
    Walter Churchill Willett, Sander Greenland, Brian MacMahon, Dimitrios Trichopoulos, Kenneth Jay Rothman, David Brynmor Thomas, Michael J. Thun, Noel S. Weiss · 1995 · Science
  86. Teoria epidemiológica hoje: fundamentos, interfaces e tendências
    Naomar de Almeida Filho, Maurício L. Barreto, Renato Peixoto Veras, Rita Barradas Barata · 1998 · Editora FIOCRUZ eBooks
  87. Current development in clinical trials: issues old and new
    David L. DeMets · 2012 · Statistics in Medicine
  88. Air Quality, Health Effects and Management of Ammonia Emissions from Fertilizers
    Shabtai Bittman, Jeffrey Robert Brook, Albert Bleeker, Tom W. Bruulsema · 2013 · Springer eBooks
  89. Hormesis, biological plasticity, and implications for clinical trial research
    Edward J. Calabrese, Peter Pressman, Andrew Wallace Hayes, Gaurav Dhawan, Rachna Kapoor, Vittorio Calabrese, Evgenios Agathokleous, Ivo Iavicoli, James Giordano · 2023 · Ageing Research Reviews
  90. Evaluation of the causal framework used for setting National Ambient Air Quality Standards
    Julie E. Goodman, Robyn L. Prueitt, Sonja N. Sax, Lisa A. Bailey, Lorenz R. Rhomberg · 2013 · Critical Reviews in Toxicology
  91. Epidemiology in the Regulatory Arena
    Lynn R. Goldman · 2001 · American Journal of Epidemiology
  92. Direct-to-Consumer and Physician Promotion of Tegaserod Correlated With Physician Visits, Diagnoses, and Prescriptions
    Spencer D. Dorn, Joel F. Farley, Richard A. Hansen, Nilay D. Shah, Robert S. Sandler · 2009 · Gastroenterology
  93. Work that Matters
    Howard Frumkin · 2015 · Epidemiology
  94. Anomalies in the dosing of diltiazem
    Peter E. Pool · 2000 · Clinical Cardiology
  95. Hormone replacement therapy and breast cancer
    Jo Marsden · 2000 · Maturitas
  96. Clinical trials in the new millennium
    David L. DeMets · 2002 · Statistics in Medicine
  97. Drinking water and endemic gastrointestinal illness
    Martha I Sinclair, Christopher Kincaid Fairley · 2000 · Journal of Epidemiology & Community Health
  98. Carcinogenic Human Health Risks Associated with Consuming Contaminated Fish from Five Great Lakes Areas of Concern
    Judy L. Crane · 1996 · Journal of Great Lakes Research
  99. Why is prevention so difficult and slow?
    Erik Allander, B. I. B. Lindahl · 1997 · Scandinavian Journal of Social Medicine
  100. Counterfactual and interventionist approach to cure risk factor epidemiology
    Arnaud Chioléro · 2016 · International Journal of Epidemiology